Results 251 to 260 of about 110,820 (315)

Recommendations for the Reporting of Surgical Specimens Containing Uterine Cervical Neoplasms [PDF]

American Journal of Clinical Pathology, 2000
W. Dwayne Lawrence, Fadi W. Abdul-Karim, Christopher Crum, Yao-Shi Fu   +3 more
  +9 more sources

Geolocation of uterine cervical neoplasms (UCN) in the context of a prevention program in Tucumán, Argentina.

Journal of Clinical Oncology, 2021
e13535 Background: : UCN is one of the major public health problems in Tucumán, that must be related to the type of population to which it belongs (Rural or Urban). Geolocation allows the processing and analysis of geographic information whose results support decision-making in solving complex planning and management problems on the territory.
Silvia Victoria Holgado, Ana Vinuales, Daniel Gustavo Goroso, William Tsutomu Watanabe, Juan Jose Zarba, Adriana Gonzalez, Natalia Bliss, Italia Vega   +7 more
openaire   +2 more sources

TLR9 gene polymorphism −1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population

Journal of Cancer Research and Clinical Oncology, 2017
The aim of this work was to evaluate the association of single nucleotide polymorphisms in TLR9 (-1486 T/C [rs187084], -1237T/C [rs5743836] and G2848A [rs352140]) with HPV infection, squamous intraepithelial lesions, and uterine cervical neoplasm in a Mexican population.
Cecilia Martínez-Campos, Margarita Bahena-Román, Kirvis Torres-Poveda, Ana I. Burguete-García, Vicente Madrid-Marina   +4 more
openaire   +4 more sources

Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays

Gynecologic Oncology, 2005
Cyclooxygenase-2 (COX-2) and c-erbB-2 are involved in the pathogenesis of solid organ tumors. Chemotherapeutic agents targeting COX-2 and c-erbB-2 are used to treat colon and breast cancers. This study evaluated the significance and relationship of COX-2 and c-erbB-2 protein expression in untreated uterine cervical neoplasm.This study included 332 ...
Jung Yeon, Kim, Sung Jig, Lim, Kyeongmee, Park, Chul-Min, Lee, Juree, Kim   +4 more
openaire   +3 more sources

[Treatment for recurrence of uterine cervical neoplasms].

Gan to kagaku ryoho. Cancer & chemotherapy, 2009
Naonori, Sakamoto, Ichio, Fukasawa, Noriyuki, Inaba   +2 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Clinical Significance of p27 and Skp2 Protein Expression in Uterine Cervical Neoplasm

International Journal of Gynecological Pathology, 2007
The loss of p27 indicates a poor prognosis in various solid tumors, and a decrease in p27 level is the result of increased degradation by Skp2. We evaluated the relationship of p27 and Skp2 protein expression to various clinicopathologic factors in 332 cases of untreated uterine cervical neoplasm using tissue microarray method.
Jung Yeon, Kim, Sung-Jig, Lim, Hyun-Jung, Kim, Eunah, Shin, Kyeongmee, Park, Chul-Min, Lee   +5 more
openaire   +2 more sources

The Relationship of NSD to Reactions and Complications Following Treatment for Malignant Uterine Cervical Neoplasms

Radiology, 1974
In an attempt to relate nominal standard dose (NSD) to reactions and complications, the records of 516 patients who had received high dose radiotherapy for invasive squamous cell carcinoma of the uterine cervix were studied. There were two treatment plans: (a) Plan I: two applications of intracavitary radiation plus parametrial radiation; and (b) Plan ...
D A, Buchler, J C, Kline, B M, Peckham, F, Ellis   +3 more
openaire   +2 more sources

Gynecologic Neoplasms: Cervical, Ovarian, Vulvar, Uterine, and Endometrial Cancer

2016
This chapter illustrates clinical case examples demonstrating clinical utility and diagnostic performance of FDG PET-CT scans in gynecologic neoplasms which includes, cervical, ovarian, vulvar, uterine, and endometrial cancers.
Bhushan Desai, Hossein Jadvar
openaire   +1 more source

[Estimation of health-care costs for cervical uterine neoplasm].

Revista medica del Instituto Mexicano del Seguro Social, 2012
to value diagnostic stage and direct costs due to cervical cancer in insured workers and IMSS beneficiaries patients, during first year of treatment.80 records of patients with confirmed diagnosis of cervical cancer during 2000-2003 were analyzed. The study was made under provider public health services perspective, with focus in costs incidence during
Francisco Raúl, Sánchez-Román, Fernando, de Jesús Carlos-Rivera, Jorge Antonio, Guzmán-Caniupan, Pedro, Escudero-de Los Ríos, Cuauhtémoc Arturo, Juárez-Pérez, Guadalupe, Aguilar-Madrid   +5 more
openaire   +1 more source